Predictions
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.70
18.04.22
18.04.22
-
18.04.23
18.04.23
-3.95%
30.04.22
30.04.22
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.03
11.11.21
11.11.21
€2.90
11.11.22
11.11.22
-21.78%
28.04.22
28.04.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.71
15.07.21
15.07.21
-
15.07.22
15.07.22
1.92%
23.04.22
23.04.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.15
21.03.22
21.03.22
€4.00
21.03.23
21.03.23
11.30%
04.04.22
04.04.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.15
19.03.22
19.03.22
€0.000
19.03.23
19.03.23
11.30%
02.04.22
02.04.22
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
20.02.22
20.02.22
€13.00
20.02.23
20.02.23
-
17.03.22
17.03.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.34
14.03.22
14.03.22
€4.00
14.03.23
14.03.23
4.29%
16.03.22
16.03.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Canopy Growth Corp
Start price
Target price
Perf. (%)
€11.19
08.11.21
08.11.21
€10.00
08.11.22
08.11.22
-52.24%
14.03.22
14.03.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.27
20.02.22
20.02.22
-
20.02.23
20.02.23
-34.89%
05.03.22
05.03.22
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.85
20.02.22
20.02.22
-
20.02.23
20.02.23
-14.37%
05.03.22
05.03.22
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€16.47
19.03.21
19.03.21
€13.00
19.03.22
19.03.22
-22.87%
20.02.22
20.02.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.02
16.02.22
16.02.22
-
16.02.23
16.02.23
-10.26%
19.02.22
19.02.22
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€7.83
09.02.22
09.02.22
-
09.02.23
09.02.23
-12.11%
18.02.22
18.02.22
Probably not worthwhile Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€36.00
07.02.21
07.02.21
-
07.02.22
07.02.22
-80.67%
08.02.22
08.02.22
Probably not worthwhile Investment
High risks for its business
Few uniques
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.52
23.01.22
23.01.22
-
23.01.23
23.01.23
7.06%
06.02.22
06.02.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
23.01.22
23.01.22
-
23.01.23
23.01.23
15.82%
06.02.22
06.02.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.43
23.01.22
23.01.22
-
23.01.23
23.01.23
7.21%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.62
14.01.22
14.01.22
-
14.01.23
14.01.23
-12.67%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year